Menu

Investors

SEC Filings

SEC Filings

Filing date Form Description View
March 28, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 16, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
April 23, 2024 8-K

Report of unscheduled material events or corporate event

View HTML
May 9, 2024 8-K

Report of unscheduled material events or corporate event

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 22, 2014 8-K/A

Amendment to a previously filed 8-K

View HTML
September 22, 2014 8-K/A

Amendment to a previously filed 8-K

View HTML
December 14, 2016 8-K/A

Amendment to a previously filed 8-K

View HTML
December 20, 2018 8-K/A

Amendment to a previously filed 8-K

View HTML
December 15, 2021 8-K/A

Amendment to a previously filed 8-K

EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 28, 2023 ARS

An annual report to security holders

View HTML

Data provided by Kaleidoscope.

Print Page
Email Page
Contact IR
Email Alerts
Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098  phone
+1 617.871.2099  fax

Contact Us